Inventiva S.A Total Assets 2020-2021 | IVA

Inventiva S.A total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Inventiva S.A Annual Total Assets
(Millions of US $)
2020 $159
2019 $64
Inventiva S.A Quarterly Total Assets
(Millions of US $)
2021-06-30 $141
2021-03-31 $159
2020-03-31 $72
2019-12-31 $64
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.518B $0.000B
Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69